Artificial intelligence and colorectal neoplasia detection performances in patients with positive fecal immunochemical test: Meta-analysis and systematic review.

Objectives

The combination of fecal immunochemical test (FIT) followed by colonoscopy has established itself as one of the preferred population-based screening strategies. Despite extensive exploration of various techniques and technologies, their impact on adenoma detection rate has shown inconsistency across studies in this specific setting "FIT+ population." We aimed to assess the impact of the computer-aided detection (CADe) system in all randomized trials focused on this subpopulation.

Methods

We searched MEDLINE, EMBASE, and Scopus databases until September 2023 for randomized controlled trials reporting diagnostic accuracy of CADe systems for detection of colorectal neoplasia. The primary outcome was pooled adenoma detection rate, and secondary outcomes were adenoma per colonoscopy, advanced adenoma per colonoscopy, serrated lesions, and nonneoplastic per colonoscopy.

Results

Ten randomized trials on 5421 patients were included. Adenoma detection rate was higher in the CADe group than in the standard colonoscopy group (0.62 vs. 0.52; relative risk 1.19; 95% confidence interval 1.08-1.31). CADe also resulted in higher detection performances of both adenomas (incidence rate ratio 1.16; 95% confidence interval 1.09-1.24) and serrated lesions (incidence rate ratio, 1.20; 95% confidence interval 1.05-1.38) at per-polyp analysis. No differences were found for advanced adenomas between the groups. On the other hand, more nonneoplastic polyps were removed in the CADe than the standard group (0.45 vs. 0.34; mean difference 0.06; P = 0.026) in a comparable inspection time.

Conclusions

The use of CADe during colonoscopy results in an increased detection of adenomas, and serrated lesions, in a FIT+ setting. The impact on advanced adenomas was not significant. Higher rates of unnecessary removal of nonneoplastic polyps were also reported.

References:

• Sung H, Ferlay J, Siegel RL et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209–249.
• Zorzi M, Antonelli G, Barbiellini Amidei C et al. Adenoma detection rate and colorectal cancer risk in fecal immunochemical test screening programs: An observational cohort study. Ann Intern Med 2023; 176 (3): 303–310.
• Wisse PHA, Erler NS, de Boer SY et al. Adenoma detection rate and risk for interval postcolonoscopy colorectal cancer in fecal immunochemical test–based screening. Ann Intern Med 2022; 175: 1366–1373.
• Thayalasekaran S, Frazzoni L, Antonelli G et al. Endoscopic technological innovations for neoplasia detection in organized colorectal cancer screening programs: A systematic review and meta‐analysis. Gastrointest Endosc 2020; 92: 840–847.e9.
• Hassan C, Spadaccini M, Mori Y et al. Real‐time computer‐aided detection of colorectal neoplasia during colonoscopy: A systematic review and meta‐analysis. Ann Intern Med 2023; 176: 1209–1220.